Case Reports
Vol. 4 No. 1 (2012): Reviews, Articles, Case Reports and Letters
https://doi.org/10.4084/mjhid.2012.041

Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 19, 2012
1592
Views
594
Downloads
555
HTML
myeloma, CT/PET, lenalidomide
hematology

Authors

Alessandro Gozzetti
gozzetti@unisi.it
Gozzetti A, Division of Hematology and Transplants, University of Siena, Policlinico "Santa Maria alle Scotte", Viale Bracci 16 53100 Siena, Italy., Italy.
Vania Rossi
Medicina Nucleare Ospedale Arezzo, Italy.
Alfonso Cerase
Unit NINT Neuroimaging and Neurointervention, Department of Neurological and Sensorial Sciences, Azienda Ospedaliera Universitaria Senese, Policlinico “Santa Maria alle Scotte”, Siena, Italy, Italy.
Giulia Papini
Hematology Siena, Italy.
Marzia Defina
hematology Siena, .
Monica Bocchia
Hematology Siena, Italy.
A71 year old female with multiple myeloma presented with back pain seven year after autologous stem cell transplant. Skeletal bone survey and magnetic resonance imaging did not show a relapse that was evidenced by CT/PET. Lenalidomide as single agent induced a complete disappearance of the lesions 6 months later at CT/PET

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Ethics Approval

Case Image
Alessandro Gozzetti, Gozzetti A, Division of Hematology and Transplants, University of Siena, Policlinico "Santa Maria alle Scotte", Viale Bracci 16 53100 Siena, Italy.
na
Vania Rossi, Medicina Nucleare Ospedale Arezzo
na
Giulia Papini, Hematology Siena
na
Monica Bocchia, Hematology Siena
na

How to Cite



“Single agent lenalidomide activity in multiple myeloma relapse evidenced uniquely by CT/PET” (2012) Mediterranean Journal of Hematology and Infectious Diseases, 4(1), p. e2012041. doi:10.4084/mjhid.2012.041.